1. Home
  2. CCLD vs PYPD Comparison

CCLD vs PYPD Comparison

Compare CCLD & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareCloud Inc.

CCLD

CareCloud Inc.

N/A

Current Price

$1.99

Market Cap

98.6M

Sector

Technology

ML Signal

N/A

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

N/A

Current Price

$5.01

Market Cap

107.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCLD
PYPD
Founded
1999
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.6M
107.0M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
CCLD
PYPD
Price
$1.99
$5.01
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$7.33
★ $11.75
AVG Volume (30 Days)
★ 205.3K
81.6K
Earning Date
11-05-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 135.71
N/A
EPS
N/A
★ N/A
Revenue
★ $120,499,000.00
N/A
Revenue This Year
$8.14
N/A
Revenue Next Year
$9.63
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 8.72
N/A
52 Week Low
$1.93
$3.10
52 Week High
$3.81
$5.73

Technical Indicators

Market Signals
Indicator
CCLD
PYPD
Relative Strength Index (RSI) 40.85 45.12
Support Level N/A $5.00
Resistance Level $2.42 $5.07
Average True Range (ATR) 0.07 0.26
MACD 0.00 -0.05
Stochastic Oscillator 33.96 32.50

Price Performance

Historical Comparison
CCLD
PYPD

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: